“Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S40. doi:10.25251/skin.2.supp.40.